Home » Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
Prostate cancer has been one of the hot fields for new biotech drug development
this year, and now Cambridge, MA-based Tokai Pharmaceuticals is getting into the game with a drug that it hopes will someday help men live longer and push
the boundaries of science even further.
Xconomy
Xconomy
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May